Eloxx Pharmaceuticals (ELOX) Short Interest Ratio & Short Volume

Short interest is the volume of Eloxx Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 35,700 shares of ELOX short. 1.49% of Eloxx Pharmaceuticals' shares are currently sold short. Learn More on Eloxx Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELOX shares currently have a short interest ratio of 1.0. Learn More on Eloxx Pharmaceuticals's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eloxx Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.49% of Eloxx Pharmaceuticals' floating shares are currently sold short.

Eloxx Pharmaceuticals saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 35,700 shares, an increase of 66.0% from the previous total of 21,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Eloxx Pharmaceuticals currently has issued a total of 3,140,000 shares. Some of Eloxx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eloxx Pharmaceuticals currently has a public float of 2,400,000 shares.

1.49% of Eloxx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Eloxx Pharmaceuticals: Avalon GloboCare Corp. (1.74%), TRACON Pharmaceuticals, Inc. (32.67%), Gamida Cell Ltd. (7.11%), Windtree Therapeutics, Inc. (0.54%), Finch Therapeutics Group, Inc. (1.70%), Palisade Bio, Inc. (0.21%), TC Biopharm (Holdings) Plc (30.07%), Scinai Immunotherapeutics Ltd. (0.29%), Fresh Tracks Therapeutics, Inc. (0.17%), Acorda Therapeutics, Inc. (0.66%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.82 billion), T-Mobile US, Inc. ($3.69 billion), Occidental Petroleum Co. ($2.90 billion), TC Energy Co. ($2.74 billion), Tractor Supply ($2.28 billion), Rivian Automotive, Inc. ($1.92 billion), Moderna, Inc. ($1.77 billion), Celsius Holdings, Inc. ($1.72 billion), Coinbase Global, Inc. ($1.66 billion), and Royal Caribbean Cruises Ltd. ($1.65 billion). View all of the most shorted stocks.

Short selling ELOX is an investing strategy that aims to generate trading profit from Eloxx Pharmaceuticals as its price is falling. ELOX shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Eloxx Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ELOX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELOX, twice per month. The most recent reporting period available is October, 15 2023.